BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Prognosis
10 results:

  • 1. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis.
    Ding D; Wang D; Qin Y
    Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in pancreatic cancer.
    Jiang W; Du Y; Zhang W; Zhou W
    Can J Gastroenterol Hepatol; 2022; 2022():4661929. PubMed ID: 36406148
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
    Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L
    BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long Noncoding RNA malat1 Promotes Aggressive pancreatic cancer Proliferation and Metastasis via the Stimulation of Autophagy.
    Li L; Chen H; Gao Y; Wang YW; Zhang GQ; Pan SH; Ji L; Kong R; Wang G; Jia YH; Bai XW; Sun B
    Mol Cancer Ther; 2016 Sep; 15(9):2232-43. PubMed ID: 27371730
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.
    Taucher V; Mangge H; Haybaeck J
    Cell Oncol (Dordr); 2016 Aug; 39(4):295-318. PubMed ID: 27060060
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.
    Han T; Jiao F; Hu H; Yuan C; Wang L; Jin ZL; Song WF; Wang LW
    Oncotarget; 2016 Mar; 7(10):11194-207. PubMed ID: 26848980
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.
    Yang H; Liu Z; Yuan C; Zhao Y; Wang L; Hu J; Xie D; Wang L; Chen D
    Int J Clin Exp Pathol; 2015; 8(9):11092-9. PubMed ID: 26617828
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long Noncoding RNA MALAT-1 Can Predict Metastasis and a Poor prognosis: a Meta-Analysis.
    Zhu L; Liu J; Ma S; Zhang S
    Pathol Oncol Res; 2015 Sep; 21(4):1259-64. PubMed ID: 26159858
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Overexpression of long non-coding RNA malat1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
    Pang EJ; Yang R; Fu XB; Liu YF
    Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Upregulation of long non-coding RNA malat1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
    Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.